Evidence map›Paper›PMID 34429313›Full record

Trial reportBMJ open2021

Recruitment challenges to the I CARE study: a randomised trial on general practitioner-led colon cancer survivorship care.

Laura A M Duineveld, Julien A M Vos, Thijs Wieldraaijer, Sandra C Donkervoort, Jan Wind, Henk C P M van Weert, Kristel M van Asselt, I CARE study group

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Laura A M Duineveld *Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Julien A M Vos *Department of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands j.a.m.vos@amsterdamumc.nl.ORCID 0000-0002-3383-8171
Thijs WieldraaijerDepartment of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Sandra C DonkervoortDepartment of Surgery, Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, The Netherlands.
Jan WindDepartment of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Henk C P M van WeertDepartment of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Kristel M van AsseltDepartment of General Practice, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
I CARE study group
Amsterdam University Medical Centers · NLOLVG · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe I CARE study (Improving Care After colon canceR treatment in the Netherlands) aims to compare surgeon-led to general practitioner (GP)-led colon cancer survivorship care. Recruitment to the trial took longer than expected. In this descriptive study, recruitment is critically reviewed.

settingPatients were recruited from eight Dutch medical centres.

participantsPatients treated with curative intent for stages I-III colon cancer. Target patient sample size was calculated at 300.

interventionsPatients were randomised to surgeon-led (usual) versus GP-led care, with or without access to an eHealth application (Oncokompas). OUTCOME MEASURES: Baseline characteristics of (non-)participants, reasons for non-participation and strategies to improve recruitment were reviewed.

resultsOut of 1238 eligible patients, 353 patients were included. Of these, 50 patients dropped out shortly after randomisation and before start of the intervention, resulting in a participation rate of 25%. Participants were on average slightly younger (68.1 years vs 69.3 years) and more often male (67% vs 50%) in comparison to non-participants. A total of 806 patients declined participation for reasons most often relating to research (57%), including the wish to remain in specialist care (31%) and too much effort to participate (12%). Some patients mentioned health (9%) and confrontation with the disease (5%) as a reason. In 43 cases, GPs declined participation, often related to the study objective, need for financial compensation and time restraints. The generally low participation rate led to concerns about reaching the target sample size. Methods to overcome recruitment challenges included changes to the original recruitment procedure and the addition of new study centres.

conclusionsChallenges were faced in the recruitment to a randomised trial on GP-led colon cancer survivorship care. Research on the transition of care requires sufficient time, funding and support base among patients and healthcare professionals. These findings will help inform researchers and policy-makers on the development of future practices. TRIAL REGISTRATION NUMBER: NTR4860.

Indexed as

Colonic NeoplasmsGeneral PractitionersHumansMaleSample SizeSurvivalSurvivorshipgastrointestinal tumoursprimary carequalitative research

Identifiers

PMID34429313
PMCPMC8386209
OpenAlexW3195504537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.